JP2009525285A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009525285A5 JP2009525285A5 JP2008552512A JP2008552512A JP2009525285A5 JP 2009525285 A5 JP2009525285 A5 JP 2009525285A5 JP 2008552512 A JP2008552512 A JP 2008552512A JP 2008552512 A JP2008552512 A JP 2008552512A JP 2009525285 A5 JP2009525285 A5 JP 2009525285A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- pyridin
- methyl
- phenyl
- difluoro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 19
- -1 1H- pyrrolyl Chemical group 0.000 claims 8
- 125000001072 heteroaryl group Chemical group 0.000 claims 7
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 125000000623 heterocyclic group Chemical group 0.000 claims 6
- 125000005843 halogen group Chemical group 0.000 claims 5
- 125000004076 pyridyl group Chemical group 0.000 claims 4
- 125000001544 thienyl group Chemical group 0.000 claims 4
- 125000003710 aryl alkyl group Chemical group 0.000 claims 3
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 3
- 125000001188 haloalkyl group Chemical group 0.000 claims 3
- 125000004475 heteroaralkyl group Chemical group 0.000 claims 3
- 125000002971 oxazolyl group Chemical group 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 230000002265 prevention Effects 0.000 claims 3
- 125000005017 substituted alkenyl group Chemical group 0.000 claims 3
- 125000000547 substituted alkyl group Chemical group 0.000 claims 3
- 125000004426 substituted alkynyl group Chemical group 0.000 claims 3
- 125000003107 substituted aryl group Chemical group 0.000 claims 3
- 125000001113 thiadiazolyl group Chemical group 0.000 claims 3
- HUKGURSOGGLRID-UHFFFAOYSA-N 2,6-difluoro-n-[5-[2-methyl-5-(1,3,4-oxadiazol-2-yl)phenyl]pyridin-2-yl]benzamide Chemical compound CC1=CC=C(C=2OC=NN=2)C=C1C(C=N1)=CC=C1NC(=O)C1=C(F)C=CC=C1F HUKGURSOGGLRID-UHFFFAOYSA-N 0.000 claims 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims 2
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims 2
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 claims 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims 2
- 125000004438 haloalkoxy group Chemical group 0.000 claims 2
- 125000002883 imidazolyl group Chemical group 0.000 claims 2
- 230000005931 immune cell recruitment Effects 0.000 claims 2
- 125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 claims 2
- 230000003834 intracellular effect Effects 0.000 claims 2
- 125000001786 isothiazolyl group Chemical group 0.000 claims 2
- 125000000842 isoxazolyl group Chemical group 0.000 claims 2
- SBKMPASLFIDIMS-UHFFFAOYSA-N n-[6-[2-chloro-5-(1,3-thiazol-2-yl)phenyl]pyridin-3-yl]-2,6-difluorobenzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC1=CC=C(C=2C(=CC=C(C=2)C=2SC=CN=2)Cl)N=C1 SBKMPASLFIDIMS-UHFFFAOYSA-N 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 125000001715 oxadiazolyl group Chemical group 0.000 claims 2
- 239000000651 prodrug Substances 0.000 claims 2
- 229940002612 prodrug Drugs 0.000 claims 2
- 125000003373 pyrazinyl group Chemical group 0.000 claims 2
- 125000003226 pyrazolyl group Chemical group 0.000 claims 2
- 125000002098 pyridazinyl group Chemical group 0.000 claims 2
- 125000000168 pyrrolyl group Chemical group 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims 2
- 125000003831 tetrazolyl group Chemical group 0.000 claims 2
- 125000000335 thiazolyl group Chemical group 0.000 claims 2
- 125000001425 triazolyl group Chemical group 0.000 claims 2
- NWRLYMCEXWWZLA-UHFFFAOYSA-N 2,6-difluoro-n-[4-methyl-5-[3-(1,3-oxazol-2-yl)phenyl]pyridin-2-yl]benzamide Chemical compound N=1C=C(C=2C=C(C=CC=2)C=2OC=CN=2)C(C)=CC=1NC(=O)C1=C(F)C=CC=C1F NWRLYMCEXWWZLA-UHFFFAOYSA-N 0.000 claims 1
- PPZYEZLVXHVDSH-UHFFFAOYSA-N 2,6-difluoro-n-[4-methyl-5-[3-(trifluoromethyl)phenyl]pyridin-2-yl]benzamide Chemical compound N=1C=C(C=2C=C(C=CC=2)C(F)(F)F)C(C)=CC=1NC(=O)C1=C(F)C=CC=C1F PPZYEZLVXHVDSH-UHFFFAOYSA-N 0.000 claims 1
- DECYQMUKHWDJJI-UHFFFAOYSA-N 2,6-difluoro-n-[5-(2-methyl-5-thiophen-2-ylphenyl)pyridin-2-yl]benzamide Chemical compound CC1=CC=C(C=2SC=CC=2)C=C1C(C=N1)=CC=C1NC(=O)C1=C(F)C=CC=C1F DECYQMUKHWDJJI-UHFFFAOYSA-N 0.000 claims 1
- AXLXYUOGKRLVIH-UHFFFAOYSA-N 2,6-difluoro-n-[5-(2-methyl-5-thiophen-3-ylphenyl)pyridin-2-yl]benzamide Chemical compound CC1=CC=C(C2=CSC=C2)C=C1C(C=N1)=CC=C1NC(=O)C1=C(F)C=CC=C1F AXLXYUOGKRLVIH-UHFFFAOYSA-N 0.000 claims 1
- AFXMSIAEHKKZLP-UHFFFAOYSA-N 2,6-difluoro-n-[5-[2-methyl-5-(1,2-oxazol-5-yl)phenyl]pyridin-2-yl]benzamide Chemical compound CC1=CC=C(C=2ON=CC=2)C=C1C(C=N1)=CC=C1NC(=O)C1=C(F)C=CC=C1F AFXMSIAEHKKZLP-UHFFFAOYSA-N 0.000 claims 1
- NDWUBCJZNAEUBW-UHFFFAOYSA-N 2,6-difluoro-n-[5-[2-methyl-5-(1,3,4-thiadiazol-2-yl)phenyl]pyridin-2-yl]benzamide Chemical compound CC1=CC=C(C=2SC=NN=2)C=C1C(C=N1)=CC=C1NC(=O)C1=C(F)C=CC=C1F NDWUBCJZNAEUBW-UHFFFAOYSA-N 0.000 claims 1
- GFASVRXBQQSUKC-UHFFFAOYSA-N 2,6-difluoro-n-[5-[2-methyl-5-(1,3-oxazol-2-yl)phenyl]pyridin-2-yl]benzamide Chemical compound CC1=CC=C(C=2OC=CN=2)C=C1C(C=N1)=CC=C1NC(=O)C1=C(F)C=CC=C1F GFASVRXBQQSUKC-UHFFFAOYSA-N 0.000 claims 1
- UUNLGJFURFVLBP-UHFFFAOYSA-N 2,6-difluoro-n-[5-[2-methyl-5-(1,3-oxazol-5-yl)phenyl]pyridin-2-yl]benzamide Chemical compound CC1=CC=C(C=2OC=NC=2)C=C1C(C=N1)=CC=C1NC(=O)C1=C(F)C=CC=C1F UUNLGJFURFVLBP-UHFFFAOYSA-N 0.000 claims 1
- VKCMJRXAMSLXOS-UHFFFAOYSA-N 2,6-difluoro-n-[5-[2-methyl-5-(1,3-thiazol-2-yl)phenyl]pyridin-2-yl]benzamide Chemical compound CC1=CC=C(C=2SC=CN=2)C=C1C(C=N1)=CC=C1NC(=O)C1=C(F)C=CC=C1F VKCMJRXAMSLXOS-UHFFFAOYSA-N 0.000 claims 1
- QTROTQGBZQYHBX-UHFFFAOYSA-N 2,6-difluoro-n-[5-[2-methyl-5-(3-methyl-1,2-oxazol-5-yl)phenyl]pyridin-2-yl]benzamide Chemical compound O1N=C(C)C=C1C1=CC=C(C)C(C=2C=NC(NC(=O)C=3C(=CC=CC=3F)F)=CC=2)=C1 QTROTQGBZQYHBX-UHFFFAOYSA-N 0.000 claims 1
- FSYLOFPFHBRJNF-UHFFFAOYSA-N 2,6-difluoro-n-[5-[5-(furan-2-yl)-2-methylphenyl]pyridin-2-yl]benzamide Chemical compound CC1=CC=C(C=2OC=CC=2)C=C1C(C=N1)=CC=C1NC(=O)C1=C(F)C=CC=C1F FSYLOFPFHBRJNF-UHFFFAOYSA-N 0.000 claims 1
- CWUWPDDXRAXIQQ-UHFFFAOYSA-N 2,6-difluoro-n-[6-(2-methyl-5-pyridin-2-ylphenyl)pyridin-3-yl]benzamide Chemical compound CC1=CC=C(C=2N=CC=CC=2)C=C1C(N=C1)=CC=C1NC(=O)C1=C(F)C=CC=C1F CWUWPDDXRAXIQQ-UHFFFAOYSA-N 0.000 claims 1
- LMYUUBFMCJMOLR-UHFFFAOYSA-N 2,6-difluoro-n-[6-(2-methyl-5-pyridin-3-ylphenyl)pyridin-3-yl]benzamide Chemical compound CC1=CC=C(C=2C=NC=CC=2)C=C1C(N=C1)=CC=C1NC(=O)C1=C(F)C=CC=C1F LMYUUBFMCJMOLR-UHFFFAOYSA-N 0.000 claims 1
- NMEWXDIZTZGHPI-UHFFFAOYSA-N 2,6-difluoro-n-[6-[2-methyl-5-(1,2-oxazol-5-yl)phenyl]pyridin-3-yl]benzamide Chemical compound CC1=CC=C(C=2ON=CC=2)C=C1C(N=C1)=CC=C1NC(=O)C1=C(F)C=CC=C1F NMEWXDIZTZGHPI-UHFFFAOYSA-N 0.000 claims 1
- JOTOQEHANOQEIZ-UHFFFAOYSA-N 2,6-difluoro-n-[6-[2-methyl-5-(1,3,4-oxadiazol-2-yl)phenyl]pyridin-3-yl]benzamide Chemical compound CC1=CC=C(C=2OC=NN=2)C=C1C(N=C1)=CC=C1NC(=O)C1=C(F)C=CC=C1F JOTOQEHANOQEIZ-UHFFFAOYSA-N 0.000 claims 1
- GDBAUFJPNSYWPV-UHFFFAOYSA-N 2,6-difluoro-n-[6-[2-methyl-5-(1,3-oxazol-2-yl)phenyl]pyridin-3-yl]benzamide Chemical compound CC1=CC=C(C=2OC=CN=2)C=C1C(N=C1)=CC=C1NC(=O)C1=C(F)C=CC=C1F GDBAUFJPNSYWPV-UHFFFAOYSA-N 0.000 claims 1
- CLOSKACXUFZBRR-UHFFFAOYSA-N 2,6-difluoro-n-[6-[2-methyl-5-(1,3-oxazol-2-yl)phenyl]pyridin-3-yl]benzamide;hydrochloride Chemical compound Cl.CC1=CC=C(C=2OC=CN=2)C=C1C(N=C1)=CC=C1NC(=O)C1=C(F)C=CC=C1F CLOSKACXUFZBRR-UHFFFAOYSA-N 0.000 claims 1
- YWHOFKIZMLMQPA-UHFFFAOYSA-N 2,6-difluoro-n-[6-[2-methyl-5-(1,3-oxazol-5-yl)phenyl]pyridin-3-yl]benzamide Chemical compound CC1=CC=C(C=2OC=NC=2)C=C1C(N=C1)=CC=C1NC(=O)C1=C(F)C=CC=C1F YWHOFKIZMLMQPA-UHFFFAOYSA-N 0.000 claims 1
- HRTIYJHWFWOWGT-UHFFFAOYSA-N 2,6-difluoro-n-[6-[2-methyl-5-(1,3-thiazol-2-yl)phenyl]pyridin-3-yl]benzamide Chemical compound CC1=CC=C(C=2SC=CN=2)C=C1C(N=C1)=CC=C1NC(=O)C1=C(F)C=CC=C1F HRTIYJHWFWOWGT-UHFFFAOYSA-N 0.000 claims 1
- DIMXDMFCZWDJBH-UHFFFAOYSA-N 2,6-difluoro-n-[6-[2-methyl-5-(1,3-thiazol-2-yl)phenyl]pyridin-3-yl]benzamide;hydrochloride Chemical compound Cl.CC1=CC=C(C=2SC=CN=2)C=C1C(N=C1)=CC=C1NC(=O)C1=C(F)C=CC=C1F DIMXDMFCZWDJBH-UHFFFAOYSA-N 0.000 claims 1
- XRUZPDHALZTTLS-UHFFFAOYSA-N 2,6-difluoro-n-[6-[2-methyl-5-(3-methyl-1,2-oxazol-5-yl)phenyl]pyridin-3-yl]benzamide Chemical compound O1N=C(C)C=C1C1=CC=C(C)C(C=2N=CC(NC(=O)C=3C(=CC=CC=3F)F)=CC=2)=C1 XRUZPDHALZTTLS-UHFFFAOYSA-N 0.000 claims 1
- PXMZSZIIVMKPMX-UHFFFAOYSA-N 2,6-difluoro-n-[6-methyl-5-[3-(1,3-oxazol-2-yl)phenyl]pyridin-2-yl]benzamide Chemical compound C=1C=C(C=2C=C(C=CC=2)C=2OC=CN=2)C(C)=NC=1NC(=O)C1=C(F)C=CC=C1F PXMZSZIIVMKPMX-UHFFFAOYSA-N 0.000 claims 1
- YJZGPENRMVMIKP-UHFFFAOYSA-N 2,6-difluoro-n-[6-methyl-5-[3-(trifluoromethyl)phenyl]pyridin-2-yl]benzamide Chemical compound C=1C=C(C=2C=C(C=CC=2)C(F)(F)F)C(C)=NC=1NC(=O)C1=C(F)C=CC=C1F YJZGPENRMVMIKP-UHFFFAOYSA-N 0.000 claims 1
- QPGVCUFOTYDIML-UHFFFAOYSA-N 2-methoxyethyl 4-chloro-3-[6-[(2,6-difluorobenzoyl)amino]pyridin-3-yl]benzoate Chemical compound COCCOC(=O)C1=CC=C(Cl)C(C=2C=NC(NC(=O)C=3C(=CC=CC=3F)F)=CC=2)=C1 QPGVCUFOTYDIML-UHFFFAOYSA-N 0.000 claims 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims 1
- DFRZBDVAEKXKQC-UHFFFAOYSA-N 3-methyl-n-[5-[2-methyl-5-(1,3-oxazol-2-yl)phenyl]pyridin-2-yl]pyridine-4-carboxamide Chemical compound CC1=CC=C(C=2OC=CN=2)C=C1C(C=N1)=CC=C1NC(=O)C1=CC=NC=C1C DFRZBDVAEKXKQC-UHFFFAOYSA-N 0.000 claims 1
- RWVJIELCHYOVTM-UHFFFAOYSA-N 3-methyl-n-[5-[2-methyl-5-(1,3-thiazol-2-yl)phenyl]pyridin-2-yl]pyridine-4-carboxamide Chemical compound CC1=CC=C(C=2SC=CN=2)C=C1C(C=N1)=CC=C1NC(=O)C1=CC=NC=C1C RWVJIELCHYOVTM-UHFFFAOYSA-N 0.000 claims 1
- GVCJBMBKQOHNOI-UHFFFAOYSA-N 3-methyl-n-[6-[2-methyl-5-(1,3-oxazol-2-yl)phenyl]pyridin-3-yl]pyridine-4-carboxamide Chemical compound CC1=CC=C(C=2OC=CN=2)C=C1C(N=C1)=CC=C1NC(=O)C1=CC=NC=C1C GVCJBMBKQOHNOI-UHFFFAOYSA-N 0.000 claims 1
- FVTLFUPVOZVCQU-UHFFFAOYSA-N 3-methyl-n-[6-[2-methyl-5-(1,3-thiazol-2-yl)phenyl]pyridin-3-yl]pyridine-4-carboxamide Chemical compound CC1=CC=C(C=2SC=CN=2)C=C1C(N=C1)=CC=C1NC(=O)C1=CC=NC=C1C FVTLFUPVOZVCQU-UHFFFAOYSA-N 0.000 claims 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims 1
- JQNAMYQJPCVENO-UHFFFAOYSA-N 4-methyl-n-[5-[2-methyl-5-(1,2-oxazol-5-yl)phenyl]pyridin-2-yl]thiadiazole-5-carboxamide Chemical compound N1=NSC(C(=O)NC=2N=CC(=CC=2)C=2C(=CC=C(C=2)C=2ON=CC=2)C)=C1C JQNAMYQJPCVENO-UHFFFAOYSA-N 0.000 claims 1
- HXPHZSJYBMNISB-UHFFFAOYSA-N 4-methyl-n-[5-[2-methyl-5-(1,3-oxazol-2-yl)phenyl]pyridin-2-yl]thiadiazole-5-carboxamide Chemical compound N1=NSC(C(=O)NC=2N=CC(=CC=2)C=2C(=CC=C(C=2)C=2OC=CN=2)C)=C1C HXPHZSJYBMNISB-UHFFFAOYSA-N 0.000 claims 1
- IYXMATXDEXCCEZ-UHFFFAOYSA-N 4-methyl-n-[5-[2-methyl-5-(1,3-oxazol-5-yl)phenyl]pyridin-2-yl]thiadiazole-5-carboxamide Chemical compound N1=NSC(C(=O)NC=2N=CC(=CC=2)C=2C(=CC=C(C=2)C=2OC=NC=2)C)=C1C IYXMATXDEXCCEZ-UHFFFAOYSA-N 0.000 claims 1
- 102000004310 Ion Channels Human genes 0.000 claims 1
- 210000001744 T-lymphocyte Anatomy 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 208000026935 allergic disease Diseases 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 125000005334 azaindolyl group Chemical group N1N=C(C2=CC=CC=C12)* 0.000 claims 1
- 210000003719 b-lymphocyte Anatomy 0.000 claims 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims 1
- 125000005605 benzo group Chemical group 0.000 claims 1
- 125000004618 benzofuryl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 claims 1
- 125000005874 benzothiadiazolyl group Chemical group 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 230000016396 cytokine production Effects 0.000 claims 1
- 125000004212 difluorophenyl group Chemical group 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- VCXCABXNVFWRFB-UHFFFAOYSA-N ethyl 3-[5-[(2,6-difluorobenzoyl)amino]pyridin-2-yl]-4-methylbenzoate Chemical compound CCOC(=O)C1=CC=C(C)C(C=2N=CC(NC(=O)C=3C(=CC=CC=3F)F)=CC=2)=C1 VCXCABXNVFWRFB-UHFFFAOYSA-N 0.000 claims 1
- NRDRFIQYLSOEAF-UHFFFAOYSA-N ethyl 3-[6-[(2,6-difluorobenzoyl)amino]pyridin-3-yl]-4-methylbenzoate Chemical compound CCOC(=O)C1=CC=C(C)C(C=2C=NC(NC(=O)C=3C(=CC=CC=3F)F)=CC=2)=C1 NRDRFIQYLSOEAF-UHFFFAOYSA-N 0.000 claims 1
- 125000002541 furyl group Chemical group 0.000 claims 1
- 125000004857 imidazopyridinyl group Chemical group N1C(=NC2=C1C=CC=N2)* 0.000 claims 1
- 125000005945 imidazopyridyl group Chemical group 0.000 claims 1
- 210000000987 immune system Anatomy 0.000 claims 1
- 208000026278 immune system disease Diseases 0.000 claims 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 claims 1
- 125000001041 indolyl group Chemical group 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- NVPYSBKSCXMVNN-UHFFFAOYSA-N methyl 3-(6-benzamidopyridin-3-yl)-4-chlorobenzoate Chemical compound COC(=O)C1=CC=C(Cl)C(C=2C=NC(NC(=O)C=3C=CC=CC=3)=CC=2)=C1 NVPYSBKSCXMVNN-UHFFFAOYSA-N 0.000 claims 1
- ZZNOORNVLCYZKC-UHFFFAOYSA-N methyl 3-[5-[(2,6-difluorobenzoyl)amino]pyridin-2-yl]-4-methylbenzoate Chemical compound COC(=O)C1=CC=C(C)C(C=2N=CC(NC(=O)C=3C(=CC=CC=3F)F)=CC=2)=C1 ZZNOORNVLCYZKC-UHFFFAOYSA-N 0.000 claims 1
- JPJHHRSRUNCLIC-UHFFFAOYSA-N methyl 3-[6-[(2,6-difluorobenzoyl)amino]pyridin-3-yl]-4-methylbenzoate Chemical compound COC(=O)C1=CC=C(C)C(C=2C=NC(NC(=O)C=3C(=CC=CC=3F)F)=CC=2)=C1 JPJHHRSRUNCLIC-UHFFFAOYSA-N 0.000 claims 1
- PMVUKTOGYNHOCP-UHFFFAOYSA-N methyl 4-chloro-3-[6-[(2,6-difluorobenzoyl)amino]pyridin-3-yl]benzoate Chemical compound COC(=O)C1=CC=C(Cl)C(C=2C=NC(NC(=O)C=3C(=CC=CC=3F)F)=CC=2)=C1 PMVUKTOGYNHOCP-UHFFFAOYSA-N 0.000 claims 1
- OVVKGXGJVOEFKO-UHFFFAOYSA-N methyl 4-chloro-3-[6-[(2-methylbenzoyl)amino]pyridin-3-yl]benzoate Chemical compound COC(=O)C1=CC=C(Cl)C(C=2C=NC(NC(=O)C=3C(=CC=CC=3)C)=CC=2)=C1 OVVKGXGJVOEFKO-UHFFFAOYSA-N 0.000 claims 1
- MONSMYXYRROOLM-UHFFFAOYSA-N methyl 4-chloro-3-[6-[(2-methylpyrazole-3-carbonyl)amino]pyridin-3-yl]benzoate Chemical compound COC(=O)C1=CC=C(Cl)C(C=2C=NC(NC(=O)C=3N(N=CC=3)C)=CC=2)=C1 MONSMYXYRROOLM-UHFFFAOYSA-N 0.000 claims 1
- PWGFEFJUORGBNN-UHFFFAOYSA-N methyl 4-chloro-3-[6-[(3-chloropyridine-4-carbonyl)amino]pyridin-3-yl]benzoate Chemical compound COC(=O)C1=CC=C(Cl)C(C=2C=NC(NC(=O)C=3C(=CN=CC=3)Cl)=CC=2)=C1 PWGFEFJUORGBNN-UHFFFAOYSA-N 0.000 claims 1
- VIZUGRMYZZKELJ-UHFFFAOYSA-N methyl 4-chloro-3-[6-[(3-fluoropyridine-4-carbonyl)amino]pyridin-3-yl]benzoate Chemical compound COC(=O)C1=CC=C(Cl)C(C=2C=NC(NC(=O)C=3C(=CN=CC=3)F)=CC=2)=C1 VIZUGRMYZZKELJ-UHFFFAOYSA-N 0.000 claims 1
- JNQZFAQLBXIJMV-UHFFFAOYSA-N methyl 4-chloro-3-[6-[(3-methylpyridine-4-carbonyl)amino]pyridin-3-yl]benzoate Chemical compound COC(=O)C1=CC=C(Cl)C(C=2C=NC(NC(=O)C=3C(=CN=CC=3)C)=CC=2)=C1 JNQZFAQLBXIJMV-UHFFFAOYSA-N 0.000 claims 1
- NXLSRFDUTSDIRS-UHFFFAOYSA-N methyl 4-chloro-3-[6-[(4-fluoro-1,2-thiazole-5-carbonyl)amino]pyridin-3-yl]benzoate Chemical compound COC(=O)C1=CC=C(Cl)C(C=2C=NC(NC(=O)C3=C(C=NS3)F)=CC=2)=C1 NXLSRFDUTSDIRS-UHFFFAOYSA-N 0.000 claims 1
- QSBOIJNFSPYSFK-UHFFFAOYSA-N methyl 4-chloro-3-[6-[(4-methyl-1,2-thiazole-5-carbonyl)amino]pyridin-3-yl]benzoate Chemical compound COC(=O)C1=CC=C(Cl)C(C=2C=NC(NC(=O)C3=C(C=NS3)C)=CC=2)=C1 QSBOIJNFSPYSFK-UHFFFAOYSA-N 0.000 claims 1
- LKNDFABBDHYNEP-UHFFFAOYSA-N methyl 4-chloro-3-[6-[(4-methyl-1,3-oxazole-5-carbonyl)amino]pyridin-3-yl]benzoate Chemical compound COC(=O)C1=CC=C(Cl)C(C=2C=NC(NC(=O)C3=C(N=CO3)C)=CC=2)=C1 LKNDFABBDHYNEP-UHFFFAOYSA-N 0.000 claims 1
- POILPMPGOFDIBJ-UHFFFAOYSA-N methyl 4-chloro-3-[6-[(4-methyl-1,3-thiazole-5-carbonyl)amino]pyridin-3-yl]benzoate Chemical compound COC(=O)C1=CC=C(Cl)C(C=2C=NC(NC(=O)C3=C(N=CS3)C)=CC=2)=C1 POILPMPGOFDIBJ-UHFFFAOYSA-N 0.000 claims 1
- BDNCMUFNBFWVPT-UHFFFAOYSA-N methyl 4-chloro-3-[6-[(4-methyloxadiazole-5-carbonyl)amino]pyridin-3-yl]benzoate Chemical compound COC(=O)C1=CC=C(Cl)C(C=2C=NC(NC(=O)C3=C(N=NO3)C)=CC=2)=C1 BDNCMUFNBFWVPT-UHFFFAOYSA-N 0.000 claims 1
- HGWVNXUNRDPTPZ-UHFFFAOYSA-N methyl 4-chloro-3-[6-[(4-methylthiadiazole-5-carbonyl)amino]pyridin-3-yl]benzoate Chemical compound COC(=O)C1=CC=C(Cl)C(C=2C=NC(NC(=O)C3=C(N=NS3)C)=CC=2)=C1 HGWVNXUNRDPTPZ-UHFFFAOYSA-N 0.000 claims 1
- PNVXQZPEXYZIDB-UHFFFAOYSA-N methyl 4-chloro-3-[6-[(5-methyl-2h-triazole-4-carbonyl)amino]pyridin-3-yl]benzoate Chemical compound COC(=O)C1=CC=C(Cl)C(C=2C=NC(NC(=O)C3=C(N=NN3)C)=CC=2)=C1 PNVXQZPEXYZIDB-UHFFFAOYSA-N 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- BCBUQGAHIXDSRR-UHFFFAOYSA-N n-[5-[2-chloro-5-(1,3,4-oxadiazol-2-yl)phenyl]pyridin-2-yl]-2,6-difluorobenzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC1=CC=C(C=2C(=CC=C(C=2)C=2OC=NN=2)Cl)C=N1 BCBUQGAHIXDSRR-UHFFFAOYSA-N 0.000 claims 1
- YFKOUVPVUCHLRB-UHFFFAOYSA-N n-[5-[2-chloro-5-(1,3-oxazol-2-yl)phenyl]pyridin-2-yl]-2,6-difluorobenzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC1=CC=C(C=2C(=CC=C(C=2)C=2OC=CN=2)Cl)C=N1 YFKOUVPVUCHLRB-UHFFFAOYSA-N 0.000 claims 1
- HIQSJMONWYATQC-UHFFFAOYSA-N n-[5-[2-chloro-5-(1,3-oxazol-2-yl)phenyl]pyridin-2-yl]-4-methylthiadiazole-5-carboxamide Chemical compound N1=NSC(C(=O)NC=2N=CC(=CC=2)C=2C(=CC=C(C=2)C=2OC=CN=2)Cl)=C1C HIQSJMONWYATQC-UHFFFAOYSA-N 0.000 claims 1
- MUHGILOXUDSEMX-UHFFFAOYSA-N n-[5-[2-chloro-5-(1,3-thiazol-2-yl)phenyl]pyridin-2-yl]-2,6-difluorobenzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC1=CC=C(C=2C(=CC=C(C=2)C=2SC=CN=2)Cl)C=N1 MUHGILOXUDSEMX-UHFFFAOYSA-N 0.000 claims 1
- YYJYEZBUXSUCCB-UHFFFAOYSA-N n-[5-[2-chloro-5-(1,3-thiazol-2-yl)phenyl]pyridin-2-yl]-3-methylpyridine-4-carboxamide Chemical compound CC1=CN=CC=C1C(=O)NC1=CC=C(C=2C(=CC=C(C=2)C=2SC=CN=2)Cl)C=N1 YYJYEZBUXSUCCB-UHFFFAOYSA-N 0.000 claims 1
- ZBWYIUFYKIJVSX-UHFFFAOYSA-N n-[5-[2-chloro-5-(1,3-thiazol-2-yl)phenyl]pyridin-2-yl]-4-methylthiadiazole-5-carboxamide Chemical compound N1=NSC(C(=O)NC=2N=CC(=CC=2)C=2C(=CC=C(C=2)C=2SC=CN=2)Cl)=C1C ZBWYIUFYKIJVSX-UHFFFAOYSA-N 0.000 claims 1
- RJKJOLTUDYXIOB-UHFFFAOYSA-N n-[5-[2-chloro-5-(trifluoromethyl)phenyl]-4-methylpyridin-2-yl]-2,6-difluorobenzamide Chemical compound N=1C=C(C=2C(=CC=C(C=2)C(F)(F)F)Cl)C(C)=CC=1NC(=O)C1=C(F)C=CC=C1F RJKJOLTUDYXIOB-UHFFFAOYSA-N 0.000 claims 1
- DWMOXGJVPXQFEV-UHFFFAOYSA-N n-[5-[2-chloro-5-(trifluoromethyl)phenyl]-6-methylpyridin-2-yl]-2,6-difluorobenzamide Chemical compound C=1C=C(C=2C(=CC=C(C=2)C(F)(F)F)Cl)C(C)=NC=1NC(=O)C1=C(F)C=CC=C1F DWMOXGJVPXQFEV-UHFFFAOYSA-N 0.000 claims 1
- ZSRKPIVYJAAJLH-UHFFFAOYSA-N n-[5-[2-chloro-5-(trifluoromethyl)phenyl]pyridin-2-yl]-2,6-difluorobenzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC1=CC=C(C=2C(=CC=C(C=2)C(F)(F)F)Cl)C=N1 ZSRKPIVYJAAJLH-UHFFFAOYSA-N 0.000 claims 1
- ZSDHPTIXDDQFJZ-UHFFFAOYSA-N n-[5-[2-chloro-5-(trifluoromethyl)phenyl]pyridin-2-yl]-3-fluoropyridine-4-carboxamide Chemical compound FC1=CN=CC=C1C(=O)NC1=CC=C(C=2C(=CC=C(C=2)C(F)(F)F)Cl)C=N1 ZSDHPTIXDDQFJZ-UHFFFAOYSA-N 0.000 claims 1
- UZHIPMFSDLICEF-UHFFFAOYSA-N n-[5-[2-chloro-5-(trifluoromethyl)phenyl]pyridin-2-yl]-3-methylpyridine-4-carboxamide Chemical compound CC1=CN=CC=C1C(=O)NC1=CC=C(C=2C(=CC=C(C=2)C(F)(F)F)Cl)C=N1 UZHIPMFSDLICEF-UHFFFAOYSA-N 0.000 claims 1
- QHDJCQMCUAFTJE-UHFFFAOYSA-N n-[5-[2-chloro-5-(trifluoromethyl)phenyl]pyridin-2-yl]-4-methylthiadiazole-5-carboxamide Chemical compound N1=NSC(C(=O)NC=2N=CC(=CC=2)C=2C(=CC=C(C=2)C(F)(F)F)Cl)=C1C QHDJCQMCUAFTJE-UHFFFAOYSA-N 0.000 claims 1
- RHKBALATTMMDIE-UHFFFAOYSA-N n-[5-[2-methoxy-5-(1,3-oxazol-5-yl)phenyl]pyridin-2-yl]-4-methylthiadiazole-5-carboxamide Chemical compound COC1=CC=C(C=2OC=NC=2)C=C1C(C=N1)=CC=C1NC(=O)C=1SN=NC=1C RHKBALATTMMDIE-UHFFFAOYSA-N 0.000 claims 1
- YEJSTDZSZXYVEO-UHFFFAOYSA-N n-[6-[2-chloro-5-(1,3-oxazol-2-yl)phenyl]pyridin-3-yl]-2,6-difluorobenzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC1=CC=C(C=2C(=CC=C(C=2)C=2OC=CN=2)Cl)N=C1 YEJSTDZSZXYVEO-UHFFFAOYSA-N 0.000 claims 1
- OLKOFYQDUSHFFU-UHFFFAOYSA-N n-[6-[2-chloro-5-(1,3-oxazol-2-yl)phenyl]pyridin-3-yl]-2,6-difluorobenzamide;hydrochloride Chemical compound Cl.FC1=CC=CC(F)=C1C(=O)NC1=CC=C(C=2C(=CC=C(C=2)C=2OC=CN=2)Cl)N=C1 OLKOFYQDUSHFFU-UHFFFAOYSA-N 0.000 claims 1
- WQUKFVBMUDKEKA-UHFFFAOYSA-N n-[6-[2-chloro-5-(1,3-thiazol-2-yl)phenyl]pyridin-3-yl]-2,6-difluorobenzamide;hydrochloride Chemical compound Cl.FC1=CC=CC(F)=C1C(=O)NC1=CC=C(C=2C(=CC=C(C=2)C=2SC=CN=2)Cl)N=C1 WQUKFVBMUDKEKA-UHFFFAOYSA-N 0.000 claims 1
- HVNRRCFINXZRFF-UHFFFAOYSA-N n-[6-[2-chloro-5-(1,3-thiazol-2-yl)phenyl]pyridin-3-yl]-3-methylpyridine-4-carboxamide Chemical compound CC1=CN=CC=C1C(=O)NC1=CC=C(C=2C(=CC=C(C=2)C=2SC=CN=2)Cl)N=C1 HVNRRCFINXZRFF-UHFFFAOYSA-N 0.000 claims 1
- VUEMPTLOPXVARE-UHFFFAOYSA-N n-[6-[2-chloro-5-(trifluoromethyl)phenyl]pyridin-3-yl]-2,6-difluorobenzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC1=CC=C(C=2C(=CC=C(C=2)C(F)(F)F)Cl)N=C1 VUEMPTLOPXVARE-UHFFFAOYSA-N 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 125000004287 oxazol-2-yl group Chemical group [H]C1=C([H])N=C(*)O1 0.000 claims 1
- 125000004304 oxazol-5-yl group Chemical group O1C=NC=C1* 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 230000035755 proliferation Effects 0.000 claims 1
- ZYWCXXQEIBOVLJ-UHFFFAOYSA-N propyl 4-chloro-3-[6-[(2,6-difluorobenzoyl)amino]pyridin-3-yl]benzoate Chemical compound CCCOC(=O)C1=CC=C(Cl)C(C=2C=NC(NC(=O)C=3C(=CC=CC=3F)F)=CC=2)=C1 ZYWCXXQEIBOVLJ-UHFFFAOYSA-N 0.000 claims 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 claims 1
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 230000001629 suppression Effects 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 125000005888 tetrahydroindolyl group Chemical group 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 125000000437 thiazol-2-yl group Chemical group [H]C1=C([H])N=C(*)S1 0.000 claims 1
- 125000004496 thiazol-5-yl group Chemical group S1C=NC=C1* 0.000 claims 1
- 125000004306 triazinyl group Chemical group 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76378206P | 2006-01-31 | 2006-01-31 | |
| US60/763,782 | 2006-01-31 | ||
| PCT/US2007/002790 WO2007089904A2 (en) | 2006-01-31 | 2007-01-31 | Pyridylphenyl compounds for inflammation and immune-related uses |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009525285A JP2009525285A (ja) | 2009-07-09 |
| JP2009525285A5 true JP2009525285A5 (enExample) | 2010-03-18 |
| JP5430944B2 JP5430944B2 (ja) | 2014-03-05 |
Family
ID=38328061
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008552512A Expired - Fee Related JP5430944B2 (ja) | 2006-01-31 | 2007-01-31 | 炎症および免疫関連用途のためのピリジルフェニル化合物 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20070254926A1 (enExample) |
| EP (1) | EP1984338B8 (enExample) |
| JP (1) | JP5430944B2 (enExample) |
| AU (1) | AU2007211276B2 (enExample) |
| CA (1) | CA2640049A1 (enExample) |
| DK (1) | DK1984338T3 (enExample) |
| ES (1) | ES2403368T3 (enExample) |
| PL (1) | PL1984338T3 (enExample) |
| TW (1) | TW200800188A (enExample) |
| WO (1) | WO2007089904A2 (enExample) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2922797B2 (ja) | 1994-10-07 | 1999-07-26 | 大日精化工業株式会社 | 有色絹糸の製造方法 |
| US8802721B2 (en) * | 2005-01-25 | 2014-08-12 | Synta Pharmaceuticals Corp. | Thiophene compounds for inflammation and immune-related uses |
| US7816535B2 (en) * | 2006-01-25 | 2010-10-19 | Synta Pharmaceuticals Corp. | Vinyl-phenyl derivatives for inflammation and immune-related uses |
| AU2007208239B2 (en) * | 2006-01-25 | 2013-04-18 | Synta Pharmaceuticals Corp. | Substituted aromatic compounds for inflammation and immune-related uses |
| JP2009528273A (ja) * | 2006-01-25 | 2009-08-06 | シンタ ファーマシューティカルズ コーポレーション | 炎症および免疫関連使用用の置換ビアリール化合物 |
| JP5430944B2 (ja) * | 2006-01-31 | 2014-03-05 | シンタ ファーマシューティカルズ コーポレーション | 炎症および免疫関連用途のためのピリジルフェニル化合物 |
| EP2001476A4 (en) | 2006-03-20 | 2010-12-22 | Synta Pharmaceuticals Corp | BENZOIMIDAZOLYL-PARAZINE-BASED COMPOUNDS FOR INFLAMMATION USES AND IMMUNE DISORDERS |
| US8779154B2 (en) * | 2006-09-26 | 2014-07-15 | Qinglin Che | Fused ring compounds for inflammation and immune-related uses |
| WO2008135826A2 (en) | 2007-05-03 | 2008-11-13 | Pfizer Limited | 2 -pyridine carboxamide derivatives as sodium channel modulators |
| US20120064121A1 (en) * | 2007-08-01 | 2012-03-15 | Synta Pharmaceuticals Corp. | Pyridine compounds for inflammation and immune-related uses |
| CA2696349A1 (en) * | 2007-08-15 | 2009-02-19 | President And Fellows Of Harvard College | Heterocyclic inhibitors of necroptosis |
| US8263641B2 (en) * | 2007-09-10 | 2012-09-11 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| US8389567B2 (en) * | 2007-12-12 | 2013-03-05 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| EP2321303B1 (en) | 2008-08-27 | 2019-11-27 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| US8524763B2 (en) * | 2008-09-22 | 2013-09-03 | Calcimedica, Inc. | Inhibitors of store operated calcium release |
| AU2009300318A1 (en) * | 2008-10-01 | 2010-04-08 | Synta Pharmaceuticals Corp. | Compounds for inflammation and immune-related uses |
| US8143269B2 (en) * | 2008-10-03 | 2012-03-27 | Calcimedica, Inc. | Inhibitors of store operated calcium release |
| US8618307B2 (en) * | 2009-09-16 | 2013-12-31 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| US8377970B2 (en) | 2009-10-08 | 2013-02-19 | Rhizen Pharmaceuticals Sa | Modulators of calcium release-activated calcium channel |
| US8993612B2 (en) | 2009-10-08 | 2015-03-31 | Rhizen Pharmaceuticals Sa | Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer |
| WO2011139489A2 (en) | 2010-04-27 | 2011-11-10 | Calcimedica Inc. | Compounds that modulate intracellular calcium |
| JP2013525448A (ja) | 2010-04-27 | 2013-06-20 | カルシメディカ，インク． | 細胞内カルシウムを調節する化合物 |
| US10703722B2 (en) | 2010-04-27 | 2020-07-07 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| AU2011293201B2 (en) | 2010-08-27 | 2015-11-05 | Calcimedica Inc. | Compounds that modulate intracellular calcium |
| SG189863A1 (en) * | 2010-10-30 | 2013-06-28 | Lupin Ltd | Oxazoline and isoxazoline derivatives as crac modulators |
| CN103702665B (zh) * | 2011-05-03 | 2016-08-17 | 幸讬制药公司 | 用于炎症和免疫相关用途的化合物 |
| WO2012170931A2 (en) | 2011-06-10 | 2012-12-13 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| WO2013059677A1 (en) | 2011-10-19 | 2013-04-25 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| WO2013063385A1 (en) * | 2011-10-28 | 2013-05-02 | Synta Pharmaceuticals Corp. | Compounds for inflammation and immune-related uses |
| WO2013164769A1 (en) | 2012-05-02 | 2013-11-07 | Lupin Limited | Substituted pyridine compounds as crac modulators |
| EP2844656A1 (en) | 2012-05-02 | 2015-03-11 | Lupin Limited | Substituted pyrazole compounds as crac modulators |
| WO2014059333A1 (en) | 2012-10-12 | 2014-04-17 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| US20160024098A1 (en) | 2013-03-15 | 2016-01-28 | President And Fellows Of Harvard College | Hybrid necroptosis inhibitors |
| EP3010586A1 (en) | 2013-06-21 | 2016-04-27 | Lupin Limited | Substituted heterocyclic compounds as crac modulators |
| EP3013810A1 (en) | 2013-06-24 | 2016-05-04 | Lupin Limited | Chromane and chromene derivatives and their use as crac modulators |
| WO2015127284A2 (en) * | 2014-02-21 | 2015-08-27 | Frost Biologic, Inc. | Antimitotic amides for the treatment of cancer and proliferative disorders |
| AR103807A1 (es) | 2015-02-27 | 2017-06-07 | Calcimedica Inc | Tratamiento de la pancreatitis |
| JP6738575B2 (ja) | 2015-08-07 | 2020-08-12 | カルシメディカ，インク． | 脳卒中および外傷性脳損傷の処置のためのｃｒａｃチャネル阻害剤の使用 |
| MX2020001793A (es) * | 2017-08-17 | 2020-07-22 | Ikena Oncology Inc | Inhibidores del receptor de hidrocarburos de arilo (ahr) y usos de los mismos. |
| CN113557020A (zh) | 2018-09-14 | 2021-10-26 | 瑞真药业公司 | 包含crac抑制剂和皮质类固醇的组合物及其使用方法 |
| KR20220140515A (ko) | 2020-01-13 | 2022-10-18 | 버지 애널리틱스, 인크. | 치환된 피라졸로-피리미딘 및 그의 용도 |
| EP4121089A4 (en) | 2020-03-20 | 2024-04-10 | Calcimedica, Inc. | METHODS AND COMPOSITIONS FOR THE TREATMENT OF ACUTE LUNG LESION AND ACUTE RESPIRATORY DISTRESS SYNDROME |
| US12522589B2 (en) | 2020-11-13 | 2026-01-13 | Calcimedica, Inc. | Synthesis of CRAC channel inhibitors |
| CN118084860A (zh) * | 2024-02-06 | 2024-05-28 | 中国药科大学 | 芳酰胺类化合物及其药物组合物和应用 |
| KR20250144817A (ko) * | 2024-03-27 | 2025-10-13 | 동국대학교 산학협력단 | 신규 옥사다이아졸 유도체 및 이를 포함하는 암 예방 또는 치료용 조성물 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3536809A (en) | 1969-02-17 | 1970-10-27 | Alza Corp | Medication method |
| US3598123A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
| US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
| IE58110B1 (en) | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
| US5073543A (en) | 1988-07-21 | 1991-12-17 | G. D. Searle & Co. | Controlled release formulations of trophic factors in ganglioside-lipsome vehicle |
| IT1229203B (it) | 1989-03-22 | 1991-07-25 | Bioresearch Spa | Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative. |
| US5120548A (en) | 1989-11-07 | 1992-06-09 | Merck & Co., Inc. | Swelling modulated polymeric drug delivery device |
| US5733566A (en) | 1990-05-15 | 1998-03-31 | Alkermes Controlled Therapeutics Inc. Ii | Controlled release of antiparasitic agents in animals |
| US5580578A (en) | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
| US5591767A (en) | 1993-01-25 | 1997-01-07 | Pharmetrix Corporation | Liquid reservoir transdermal patch for the administration of ketorolac |
| IT1270594B (it) | 1994-07-07 | 1997-05-07 | Recordati Chem Pharm | Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida |
| US6274171B1 (en) | 1996-03-25 | 2001-08-14 | American Home Products Corporation | Extended release formulation of venlafaxine hydrochloride |
| US6022884A (en) * | 1997-11-07 | 2000-02-08 | Amgen Inc. | Substituted pyridine compounds and methods of use |
| EP1052238A4 (en) * | 1998-01-28 | 2007-05-02 | Shionogi & Co | NEW TRICYCLIC CONNECTION |
| GB9825652D0 (en) * | 1998-11-23 | 1999-01-13 | Celltech Therapeutics Ltd | Chemical compounds |
| US6552188B2 (en) * | 2001-06-29 | 2003-04-22 | Kowa Co., Ltd. | Unsymmetrical cyclic diamine compound |
| JP4472349B2 (ja) * | 2002-02-12 | 2010-06-02 | スミスクライン ビーチャム コーポレーション | ｐ３８阻害薬として有用なニコチンアミド誘導体 |
| US20040063761A1 (en) * | 2002-08-06 | 2004-04-01 | Kuduk Scott D. | 2-(biarylalkyl)amino-3-(fluoroalkanoylamino)pyridine derivatives |
| WO2004056774A2 (en) | 2002-12-19 | 2004-07-08 | Neurogen Corporation | Substituted biphenyl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators |
| HRP20110180T1 (hr) * | 2003-07-23 | 2011-04-30 | Synta Pharmaceuticals Corporation | Spojevi za upotrebu kod upala i upotrebe vezane uz imunitet |
| GB0402137D0 (en) | 2004-01-30 | 2004-03-03 | Smithkline Beecham Corp | Novel compounds |
| GB0404574D0 (en) * | 2004-03-01 | 2004-04-07 | Spirogen Ltd | Amino acids |
| MX2007003342A (es) * | 2004-09-21 | 2007-06-05 | Synta Pharmaceutical Corp | Compuestos para inflamacion y usos relacionados con trastornos inmunitarios. |
| US7165455B2 (en) | 2004-12-18 | 2007-01-23 | Honeywell International Inc. | Surface acoustic wave sensor methods and systems |
| KR20140018997A (ko) * | 2005-01-07 | 2014-02-13 | 신타 파마슈티칼스 코프. | 염증 및 면역 관련 용도를 위한 화합물 |
| JP2009528273A (ja) * | 2006-01-25 | 2009-08-06 | シンタ ファーマシューティカルズ コーポレーション | 炎症および免疫関連使用用の置換ビアリール化合物 |
| AU2007208239B2 (en) * | 2006-01-25 | 2013-04-18 | Synta Pharmaceuticals Corp. | Substituted aromatic compounds for inflammation and immune-related uses |
| JP5430944B2 (ja) | 2006-01-31 | 2014-03-05 | シンタ ファーマシューティカルズ コーポレーション | 炎症および免疫関連用途のためのピリジルフェニル化合物 |
-
2007
- 2007-01-31 JP JP2008552512A patent/JP5430944B2/ja not_active Expired - Fee Related
- 2007-01-31 DK DK07762655.4T patent/DK1984338T3/da active
- 2007-01-31 ES ES07762655T patent/ES2403368T3/es active Active
- 2007-01-31 PL PL07762655T patent/PL1984338T3/pl unknown
- 2007-01-31 WO PCT/US2007/002790 patent/WO2007089904A2/en not_active Ceased
- 2007-01-31 AU AU2007211276A patent/AU2007211276B2/en not_active Ceased
- 2007-01-31 EP EP07762655.4A patent/EP1984338B8/en active Active
- 2007-01-31 CA CA002640049A patent/CA2640049A1/en not_active Abandoned
- 2007-01-31 TW TW096103468A patent/TW200800188A/zh unknown
- 2007-01-31 US US11/701,170 patent/US20070254926A1/en not_active Abandoned
-
2010
- 2010-03-29 US US12/749,317 patent/US8710083B2/en not_active Expired - Fee Related
-
2014
- 2014-03-12 US US14/206,059 patent/US20140187586A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009525285A5 (enExample) | ||
| AU2007211276B2 (en) | Pyridylphenyl compounds for inflammation and immune-related uses | |
| CA2533598C (en) | Method for modulating calcium ion-release-activated calcium ion channels | |
| JP2008526866A5 (enExample) | ||
| AU2007208225B2 (en) | Thiazole and thiadiazole compounds for inflammation and immune-related uses | |
| AU2006211646B2 (en) | Compounds for inflammation and immune-related uses | |
| JP5538894B2 (ja) | 炎症及び免疫関連使用のためのシクロヘキセニル−アリール化合物 | |
| AU2006208045B2 (en) | Compounds for inflammation and immune-related uses | |
| CA2834928C (en) | Compounds for inflammation and immune-related uses | |
| JP2009524677A5 (enExample) | ||
| AU2009300318A1 (en) | Compounds for inflammation and immune-related uses | |
| JP2009524678A (ja) | 炎症及び免疫関連用途のためのフェニル及びピリジル化合物 | |
| JP2009524678A5 (enExample) | ||
| JP2010540462A5 (enExample) | ||
| JP2014513122A5 (enExample) | ||
| AU2013201925A1 (en) | Phenyl and Pyridyl Compounds For Inflammation and Immune-Related Uses |